Clinical trial
Endothelial Dysfunction as a Risk Factor in HIV Study
NCT00039663 · National Institutes of Health Clinical Center (CC), NIH · Completed
Key facts
| NCT number | NCT00039663 |
|---|---|
| Title | Endothelial Dysfunction as a Risk Factor in HIV Study |
| Official title | Endothelial Dysfunction as a Risk Factor in HIV Study |
| Lead sponsor | National Institutes of Health Clinical Center (CC), NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | HIV Infections |
| Intervention type | Drug |
| Interventions | Pravastatin, Gemfibrozil, Rosiglitazone |
| Enrollment | 75 |
| Start date | May 1, 2002 |
| Completion | Oct 1, 2005 |
| First posted | Jun 7, 2002 |
| Last update posted | Mar 4, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: